<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347077</id>
  <title nil="true"/>
  <common-name>4,9-dimethyl-3-phenyl-1,7-bis(piperidin-1-ylmethyl)-4h-purino[8,7-c][1,2,4]triazine-6,8-dione</common-name>
  <description>4,9-dimethyl-3-phenyl-1,7-bis(piperidin-1-ylmethyl)-4h-purino[8,7-c][1,2,4]triazine-6,8-dione is a chemical compound with the formula C27H36N8O2. With an average molecular weight of 504.60 g/mol, 4,9-dimethyl-3-phenyl-1,7-bis(piperidin-1-ylmethyl)-4h-purino[8,7-c][1,2,4]triazine-6,8-dione is a heavy molecule.</description>
  <cas>106087-45-0</cas>
  <pubchem-id>3064965</pubchem-id>
  <chemical-formula>C27H36N8O2</chemical-formula>
  <weight>504.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T10:43:53Z</created-at>
  <updated-at type="dateTime">2026-08-31T10:43:53Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1C(=NN(C2=NC3=C(N12)C(=O)N(C(=O)N3C)CN4CCCCC4)CN5CCCCC5)C6=CC=CC=C6</moldb-smiles>
  <moldb-formula>C27H36N8O2</moldb-formula>
  <moldb-inchi>InChI=1S/C27H36N8O2/c1-20-22(21-12-6-3-7-13-21)29-34(19-32-16-10-5-11-17-32)26-28-24-23(35(20)26)25(36)33(27(37)30(24)2)18-31-14-8-4-9-15-31/h3,6-7,12-13,20H,4-5,8-11,14-19H2,1-2H3</moldb-inchi>
  <moldb-inchikey>UDUGWGFPLWIWNI-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">504.2961224</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342970</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4,9-dimethyl-3-phenyl-1,7-bis(piperidin-1-ylmethyl)-4h-purino[8,7-c][1,2,4]triazine-6,8-dione</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Imidazopyrimidines</klass>
  <subklass>Purines and purine derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0297424</sync-id>
  <structure-inchikey>UDUGWGFPLWIWNI-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20000000000000000000800000000000000000008000000000000000200000000000000000000020000000000000002004000000000000020000000000000480080000000000080000008000000000200020000000000002000000048000000010000000200000000000000000000000000000020100000000000000000000108800000040000000800000000000004000800000000100020000000000000800000000040000000000000400080000000002000080000000008000000000000004004000000000000000000000000000001050008000000001000200000000010000000000000001000040000000000000000000400000000142000020000000</structure-fingerprint>
  <structure-pattern-fingerprint>7036c0108512867481da5b648178ba431a32140291172050887f78408224e9cf6c3220511f8400000148491844e0401005680227508d322541eee539c0a1c110c7110c8912d05400c090114012f20200588485f159215f7342041f625422d8c44c680d2f104c3221624f8490dd94024d288680728d21c50639382c7082590b06146c18094ef8860848860670ce2c0288b91f9a9244469e8a54231d2061c004a581d3101341b6da321b066b68d17c35144ac00403a9410c401aa26a38ecc00213a11050e4449817b3d9c1b682575143d90de16110034450208d6122842a000300913869389aad4324114a0411d936a4820c51063094c6043e130890007e010a62</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKgAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:45:39Z</structure-indexed-at>
</compound>
